Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients:Week 52 results from the STEPIn study

Autor: Lars Iversen, Curdin Conrad, Liv Eidsmo, Antonio Costanzo, Joanna Narbutt, Andreas Pinter, Külli Kingo, Raquel Rivera Diaz, Frank Kolbinger, ManikPrabhu Nanna, Jennifer Annika Frueh, Piotr Jagiello

Publikováno v: Iversen, L, Conrad, C, Eidsmo, L, Costanzo, A, Narbutt, J, Pinter, A, Kingo, K, Rivera diaz, R, Kolbinger, F, Nanna, M, Frueh, J A & Jagiello, P 2023, ' Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients : Week 52 results from the STEPIn study ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 5, pp. 1004-1016 . https://doi.org/10.1111/jdv.18846
Iversen, L, Conrad, C, Eidsmo, L, Costanzo, A, Narbutt, J, Pinter, A, Kingo, K, Rivera Diaz, R, Kolbinger, F, Nanna, M, Frueh, J A & Jagiello, P 2023, ' Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients : Week 52 results from the STEPIn study ', Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 37, no. 5, pp. 1004-1016 . https://doi.org/10.1111/jdv.18846

Background: Biologic treatments have been studied mainly in patients with a long-term history of psoriasis and previous treatment failures. Objectives: The purpose of this primary analysis of the STEPIn study is to determine whether early interventio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a2c0a4e81aeb5fccdb5e0a136ac5f12
https://curis.ku.dk/ws/files/356899332/Acad_Dermatol_Venereol_2023_Iversen_Secukinumab_demonstrates_superiority_over_narrow_band_ultraviolet_B_phototherapy.pdf